Aspiration & Biopsy Needles Market

Aspiration & Biopsy Needles Market by Product (Fine-needle Aspiration, Biopsy (Core & Vacuum Assisted)), Site, Procedure (Image-guided (Ultrasound, MRI, Stereotactic), Nonimage-guided), Enduser (Hospital, Academia) - Global Forecast to 2024

Report Code: MD 7195 Jun, 2019, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Aspiration & Biopsy Needles Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Aspiration & Biopsy Needles Market

Request For Special Pricing

Aspiration and Biopsy Needles Market

Global Aspiration and Biopsy Needles Market is expected to grow at a CAGR of 7.3%.

Major market players in Aspiration and Biopsy Needles Market

Key market players profiled in the aspiration and biopsy needles market report includes

  • Becton, Dickinson and Company (US)
  • Cook Group Incorporated (US)
  • Merit Medical Systems (US)
  • Olympus Corporation (Japan)
  • Medtronic plc (Ireland)
  • CONMED Corporation (US)
  • Boston Scientific Corporation (US)
  • Becton, Dickinson and Company (BD)- was a leading player in the aspiration and biopsy needles market in 2018. The company’s aspiration and biopsy needles portfolio includes interventional specialties biopsy needles, fine needles, aspiration needles, core instruments, and prostate biopsy needles. The company recently acquired C.R Bard, which helped BD strengthen its biopsy product line in the aspiration and biopsy needles market. C. R. Bard’s long term presence in the market and established brand position has helped BD to gain the largest share of the aspiration and biopsy needles market. Besides the company's strong distribution network and widespread geographical presence, strategic acquisitions are expected to help boost BD’s market growth to a significant extent during the forecast period.
  • Cook Group - held the second position in the aspiration and biopsy needles market in 2018. The company’s large market share is attributed to its broad portfolio of products and its vast geographical presence across 135 countries. Cook offers a broad range of aspiration and biopsy needles for procedures, such as bone biopsy, breast lesion localization, and endoscopy. The Cook Group has a significant geographical presence in emerging Asian countries while having sales and marketing offices all over the globe.
  • Boston Scientific Corporation - is among the top global market players in the aspiration and biopsy needles market. Over the years, the company has focused on various organic growth strategies such as product launches to strengthen its market position in the endoscopic biopsy devices market. In January 2017, the company launched the Acquire Endoscopic Ultrasound Fine Needle Biopsy (FNB) device. With the major focus laid on research & development, expanding its existing product portfolio, and geographical expansion, the company is expected to witness considerable growth in the aspiration and biopsy needles market during the forecast period.
  • CONMED Corporation - is one of the leading market players in the aspiration and biopsy needles market. The company offers multiple aspiration biopsy needles with ultrasound guidance technique, enabling the surgeon to ensure a safe minimally invasive procedure. Further, its advanced fine aspiration needle allowing the Endoscopist to perform aspiration safely is one of the company’s endeavors to sustain growth in the segment. Conmed is likely to strengthen its market position and monitor growth with its established brand position, strong distribution network, and widespread geographical presence during the forecast period.
  • Cook- is one of the leading players of the aspiration and biopsy needles market. The company has a strong portfolio offering a wide variety of biopsy products along with aspiration and biopsy needles offered in reproductive health, gastroenterology, urology, bone biopsy, and interventional cardiology. With a strong geographic presence and sales network in 135 countries, the Cook group is bound to witness high growth in this market during the forecast period. The company also focuses on strengthening its product portfolio by launching new products. For instance, in 2016, it added the EchoTip ProCore 20 Gage Needle to its EchoTip ProCore product portfolio. Hence, these strategic initiatives have helped the company to strengthen its presence in respective regional markets, strengthen its revenue base, and offer its customers advanced products.
  • Medtronic - is an important player in the aspiration and biopsy needles market owing to its broad portfolio of surgical products and significant geographical presence in emerging Asian countries, such as China, Korea, and India. The company offers biopsy products through its Covidien business group. Medtronic is expected to witness sustainable growth in the forecast period owing to its extensive, technologically advanced product portfolio and wide geographical presence in over 160 countries and with almost 89 manufacturing sites spread across the globe.

Aspiration and Biopsy Needles: Major product type

  • Biopsy Needles
  • Aspiration Needles
  • Biopsy Needles - A biopsy is a procedure to remove a piece of tissue or sample of cells from the body for diagnostic purposes. It helps determine the presence of cancer or some other condition like inflammation and intense infection in a particular organ. During a needle biopsy, an experienced doctor uses a special needle to extract cells from a suspicious area for further diagnosis, including tumors, lumps, and enlarged lymph nodes. The biopsy needles segment accounted for the largest share of the aspiration and biopsy needles market in 2018. This can be attributed to the rising prevalence of cancer and increasing preference for minimally invasive diagnostic procedures with aspiration and biopsy needles.
  • Aspiration Needles - The needles used for FNA biopsy are thinner than a core biopsy needle. Typically, the needle size used for this biopsy procedure is 21-gauge. The use of such needles is recommended for areas such as cysts (fluid-filled lumps), nodules or masses (solid lumps), and enlarged lymph nodes. Their effectiveness and low cost have contributed to market growth.

Aspiration and Biopsy Needles: Major Sites

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Breast Cancer - In a breast biopsy, a small sample of breast tissue is extracted for breast cancer screening. Fine-needle aspiration, core needle biopsy, and surgical biopsy are common types of breast biopsy procedures. The rising prevalence of breast cancer and the growing awareness about the disease are the major factors driving the growth of this market segment. Breast cancer is considered to be the most common cancer in women globally and the most common cause of cancer deaths in women.
  • Lung Cancer - In lung biopsy procedures, a small piece of lung tissue is removed to examine or diagnose lung infections, cancer, and the cause for excess fluid in the lungs. This procedure is mainly performed using stereotactic imaging guidance. Bronchoscopic biopsy, open biopsy, and needle biopsy procedures are some of the common lung biopsy procedures.
  • Colorectal Cancer - Colorectal biopsy involves the removal and examination of suspected benign growths such as polyps and other tissue samples from the colon or rectum to check for infections or cancer cells. It is also recommended to identify the cause of blood, mucus, or pus in the stool, diagnosis of amyloidosis, and to have a definitive diagnosis of rectal cancer. Sometimes, this procedure uses CT, ultrasound, and MRI as a guidance technique.
  • Prostate Cancer - A prostate biopsy is a surgical procedure to remove samples of suspicious tissue called “cores” from the prostate. During a prostate biopsy procedure, a biopsy needle is used to collect a number of tissue samples of several thin cylindrical cores of the prostate tissue from the prostate gland for microscopic examination by a pathologist. Prostate biopsy can be performed by two methods—transrectal and transperineal biopsy.

Aspiration and Biopsy Needles Market: Major Procedures

  • Image-guided Procedures
  • Nonimage-guided Procedures
  • Image-guided Procedures - A biopsy is a minimally invasive method of sampling tissue to determine if it is benign, malignant, or infectious in the particular site/organ. An image-guided biopsy uses imaging technology that enables the surgeon to safely insert needles into hard-to-reach places in the body, such as the lungs, kidneys, liver, lymph nodes, and the bones. A thin guidewire may be placed or marking dye injected with X-ray, ultrasound, or CT guidance to aid the surgeon in locating the correct area for a surgical biopsy.
  • Nonimage-guided Procedures- A nonimage-guided procedure is performed without the aid of any imaging technology. It is majorly done in superficial areas of suspicious abnormality such as an inflammation or infection in different organ sites. Nonimage-guided procedures are performed in the knee and bone & bone marrow, where the surgeon is able to make out the suspected mass of cells upon superficial examination.

Aspiration and Biopsy Needles Market: Major Major End Users

  • Hospitals
  • Research Laboratories & Academic Institutes
  • Diagnostic and Imaging Centers
  • Hospitals - Hospitals form the largest end-user segment of the aspiration and biopsy needles market. They provide fully equipped state-of-the-art facilities to perform biopsy procedures for the diagnosis of any form of abnormality or suspected abnormality.
  • Research Laboratories & Academic Institutes- This segment includes government-funded medical laboratories and research universities. Research biopsies are important to study the impact of novel or new causative disease agents on the putative or suspected target. Government organizations help many academic and research institutes such as universities and cancer centers to support their shared research resources and provide funds to advance scientific goals.
  • Diagnostic and Imaging Centers - Diagnostic and imaging centers offer a full range of testing and screening solutions for disease screening such as cancer and infectious disease testing that are necessary for the better understanding of diseases and to help decide the appropriate therapeutic strategy. Owing to the increments in the number of diagnostic exams being performed, the growing incidence of chronic diseases, and rising awareness among individuals about diagnostic testing, followed by changes in lifestyles, are serving as drivers for this market.

[134 pages Report] The aspiration and biopsy needle market is estimated to grow at a CAGR of 7.3% to reach USD 1,272 Million by 2024 from USD 894 Million in 2019. Factors such as the rising prevalence of cancer, initiatives undertaken by government and global health organizations, and the increasing preference for minimally invasive procedures are the major factors driving the growth of the aspiration and biopsy needle market.

Aspiration & Biopsy Needles Market

By product, the biopsy needles segment accounted for the largest share of the aspiration and biopsy needles market

On the basis of product, the market is segmented into aspiration and biopsy needles. The biopsy needles segment accounted for the largest share of the fine needle aspiration market in 2019. The large share of this segment can be attributed to the rising prevalence of cancer and increasing preference for minimally invasive diagnostic procedures.

By site, the breast segment held the largest share of the market in 2019.

On the basis of site, the aspiration and biopsy needles market is segmented into breast, lung, colorectal, prostate, kidney, and bone & bone marrow. In 2019, the breast cancer segment accounted for the largest share of the market. The large share of this segment is mainly attributed to the rising prevalence of breast cancer, growing awareness about the disease, and increasing research activity pertaining to breast screening and diagnosis.

Image-guided procedures accounted for the largest share of the aspiration and biopsy needles market, by procedure

On the basis of procedure, the aspiration and biopsy needles market is segmented into image-guided procedures (ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and other image-guided procedures) and nonimage-guided procedures. Image-guided procedures accounted for the largest share of this market in 2018, primarily due to the provision of accuracy provided by it in locating the mass of cells and liquid hence helping it in accuracy for diagnosis.

North America accounted for the largest share of the aspiration and biopsy needles market in 2019

This report covers the aspiration and biopsy needles market across four major geographies—North America, Europe, Asia Pacific, and the Rest of the World. North America commanded the largest share of the fine needle aspiration market in 2019. Factors such as the increasing prevalence of cancer in the US and Canada and cancer awareness initiatives undertaken by local governments and global health organizations in the North America region are the key factors driving market growth.

Aspiration & Biopsy Needles Market

Key Market Players

CONMED Corporation (US), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), HAKKO CO.,LTD (Japan), and Merit Medical Systems (US) are some of the major players in the aspiration and biopsy needles market.

Scope of the report

Report Metric

Details

Market Size Available for Years

2017–2024

Base Year Considered

2018

Forecast Period

2019–2024

Currency Used

Value (USD Million)

Segments Covered

Product, Site, Procedure, End User, and Region

Geographies Covered

North America, Europe, Asia Pacific, and RoW

Companies Covered

15 major players, including
CONMED Corporation (US), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), HAKKO CO.,LTD (Japan), and Merit Medical Systems (US).

In this report, the aspiration and biopsy needles market has been segmented based on product, site, procedure, end user, and region.

Aspiration and biopsy needles market, by Product Type

  • Biopsy Needles
    • CNB Needles
    • VAB Needles
  • Aspiration Needles

Aspiration and biopsy needles market, by Site

  • Breast
  • Lung
  • Colorectal
  • Prostate
  • Kidney
  • Bone and Bone Marrow
  • Others Sites

Aspiration and biopsy needles market, by Procedure

  • Image-guided Procedures
  • Nonimage-guided Procedures

Aspiration and biopsy needles market, by End User

  • Hospitals
  • Research Laboratories & Academic Institutes
  • Diagnostic and Imaging Centers

Aspiration and biopsy needles market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)

Recent Developments Product

Launches and Approvals

  • In September 2018, Olympus (Japan) received FDA approval for its EZ Shot Plus 25 G needle
  • In April 2016, Olympus (Japan) launched aspiration biopsy needles with Side Port - Reusable (NA-2C-1)
  • In November 2015, Cook Group (US) Incorporated launched EchoTip ProCore 20 Gage Needle for ultrasound-guided fine needle biopsy (FNB)

Acquisitions

  • In January 2019, IZI Medical Products acquired Cook Medical’s soft tissue biopsy and breast localization needle product line.
  • In February 2018, Merit Medical Systems, Inc. announced the closure of its purchase of divestment assets from BD (Becton, Dickinson and Company)

Key Questions Addressed in This Reports

  • What are the strategies adopted by the top market players in the aspiration and biopsy needles market to penetrate emerging markets?
  • Who are the major players offering fine needle aspiration across major geographies?
  • Emerging countries offer opportunities for the adoption of aspiration and biopsy needles. Will this scenario continue for the next five years?
  • What are the factors impacting the growth of aspiration & biopsy needles market globally?

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency Used for the Study
    1.5 Market Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Approach
           2.1.1 Secondary Sources
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Sources
                    2.1.2.1 Key Data From Primary Sources
    2.2 Market Size Estimation
           2.2.1 Product-Based Market Estimation
           2.2.2 End User-Based Market Estimation
           2.2.3 Primary Research Validation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 31)
    4.1 Aspiration and Biopsy Needles Market Overview
    4.2 Aspiration and Biopsy Needles Market Share, By Product
    4.3 Fine Needle Aspiration Market, By End User, 2019 Vs. 2024 (USD Million)
    4.4 Aspiration and Biopsy Needles Market, By Procedure, 2019 Vs. 2024 (USD Million)
    4.5 Fine Needle Aspiration Market, By Site, 2019 Vs. 2024 (USD Million)
    4.6 Aspiration and Biopsy Needles Market, By Region

5 Market Overview (Page No. - 34)
    5.1 Market Dynamics
           5.1.1 Drivers
                    5.1.1.1 Rising Prevalence of Cancer
                    5.1.1.2 Cancer Awareness Initiatives Undertaken By Governments and Global Health Organizations
                    5.1.1.3 Increasing Preference for Minimally Invasive Biopsies
           5.1.2 Restraints
                    5.1.2.1 Risk of Infections Associated With the use of Aspiration and Biopsy Needles
           5.1.3 Opportunities
                    5.1.3.1 Emerging Economies
           5.1.4 Challenges
                    5.1.4.1 Underdeveloped Healthcare Infrastructure and Dearth of Well-Trained Radiologists and Oncologists
    5.2 Industry Trends
           5.2.1 Emergence of Liquid Biopsy

6 Aspiration and Biopsy Needles Market, By Product (Page No. - 39)
    6.1 Introduction
    6.2 Biopsy Needles
           6.2.1 Biopsy Needles Market Split, By Site, 2017–2024 (USD Million)
           6.2.2 Biopsy Needles Market Split, By Procedure, 2017–2024 (USD Million)
           6.2.3 Biopsy Needles Market Split, By End User, 2017–2024 (USD Million)
           6.2.4 CNB Needles
                    6.2.4.1 Low Procedural Costs, Accuracy, and Rapidity of Core Needle Biopsy Procedures Will Drive Demand for Associated Needles
           6.2.5 CNB Needles Market Split, By Site, 2017–2024 (USD Million)
           6.2.6 CNB Needles Market Split, By Procedure, 2017–2024 (USD Million)
           6.2.7 CNB Needles Market Split, By End User, 2017–2024 (USD Million)
           6.2.8 VAB Needles
                    6.2.8.1 High Diagnostic Specificity of Vacuum-Assisted Biopsy is Likely to Drive Market Growth
           6.2.9 VAB Needles Market Split, By Site, 2017–2024 (USD Million)
           6.2.10 VAB Needles Market Split, By Procedure, 2017–2024 (USD Million)
           6.2.11 VAB Needles Market Split, By End User, 2017–2024 (USD Million)
    6.3 Aspiration Needles
           6.3.1 Low Accuracy and the Possibility of False-Positive Results Have Hindered the Adoption of Aspiration Needles
           6.3.2 Aspiration Needles Market Split, By Site, 2017–2024 (USD Million)
           6.3.3 Aspiration Needles Market Split, By Procedure, 2017–2024 (USD Million)
           6.3.4 Aspiration Needles Market Split, By End User, 2017–2024 (USD Million)

7 Aspiration and Biopsy Needles Market, By Procedure (Page No. - 51)
    7.1 Introduction
    7.2 Image-Guided Procedures
           7.2.1 Ultrasound
                    7.2.1.1 Ultrasound is Gradually Becoming the Most Important Adjunctive Imaging Modality for Cancer Diagnosis
           7.2.2 Stereotactic
                    7.2.2.1 Stereotactic-Guided Biopsy Can Evaluate Tiny Masses Which are Not Visible Through Ultrasound
           7.2.3 Mri
                    7.2.3.1 High Cost, Limited Reimbursement, and Lengthy Procedure—Key Factors Restraining the Market Growth
           7.2.4 Other Image-Guided Procedures
    7.3 Nonimage-Guided Procedures
           7.3.1 Nonimage-Guided Procedures are Majorly Performed in Superficial Areas of Suspicious Abnormality

8 Aspiration and Biopsy Needles Market, By Site (Page No. - 59)
    8.1 Introduction
    8.2 Breast
           8.2.1 Increasing Awareness of Breast Cancer to Drive the Growth of This Market Segment
    8.3 Lung
           8.3.1 Growing Prevalence of Lung Cancer to Support the Growth of This Market Segment
    8.4 Colorectal
           8.4.1 Advancements in Alternative Diagnosis Techniques to Reduce the Adoption of Colorectal Biopsy Needles
    8.5 Prostate
           8.5.1 Availability of Funds for Prostate Cancer Research By Different Government Authorities to Support the Growth of This Market Segment
    8.6 Kidney
           8.6.1 Rising Prevalence of Kidney Cancer to Support the Growth of This Market Segment
    8.7 Bone and Bone Marrow
           8.7.1 Rising Incidence of Bone Cancer Across the Globe to Drive the Growth of This Market Segment
    8.8 Other Sites

9 Aspiration and Biopsy Needles Market, By Region (Page No. - 68)
    9.1 Introduction
    9.2 North America
           9.2.1 US
                    9.2.1.1 The US Dominates the North American Aspiration and Biopsy Needles Market Primarily Due to a Large Number of Diagnostic Imaging Procedures Performed in the Country
           9.2.2 Canada
                    9.2.2.1 Rising Prevalence of Cancer is Supporting the Adoption of Aspiration and Biopsy Needles in Canada
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 High Healthcare Spending and Per Capita Healthcare Spending in the Country to Support Market Growth
           9.3.2 UK
                    9.3.2.1 Growing Awareness and Support for Cancer-Related Activities are Propelling the Growth of the Aspiration and Biopsy Needles Market in the Country
           9.3.3 France
                    9.3.3.1 France to Register the Highest Growth in the European Aspiration and Biopsy Needles Market
           9.3.4 Rest of Europe
    9.4 APAC
           9.4.1 Japan
                    9.4.1.1 Presence of a Well-Developed Healthcare System, Coupled With the Availability of a Universal Healthcare Reimbursement Policy, is Aiding the Growth of the Aspiration and Biopsy Needles Market in Japan
           9.4.2 China
                    9.4.2.1 Rising Prevalence of Cancer and the Growing Spending Capacity of the Middle-Class Population to Drive the Market for Aspiration and Biopsy Needles in China
           9.4.3 India
                    9.4.3.1 Presence of a Large Patient Population and Growing Access to Healthcare Facilities to Support Market Growth
           9.4.4 Rest of Asia Pacific
    9.5 Rest of World (RoW)

10 Competitive Landscape (Page No. - 99)
     10.1 Introduction
     10.2 Market Ranking Analysis
     10.3 Competitive Scenario
             10.3.1 Product Launches and Approvals
             10.3.2 Acquisitions
     10.4 Competitive Leadership Mapping
             10.4.1 Competitive Leadership Mapping: Major Market Players (2017)
                       10.4.1.1 Visionary Leaders
                       10.4.1.2 Innovators
                       10.4.1.3 Dynamic Players
                       10.4.1.4 Emerging Companies

11 Company Profiles (Page No. - 103)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     11.1 Argon Medical Devices, Inc.
     11.2 Becton, Dickinson and Company (BD)
     11.3 Boston Scientific Corporation
     11.4 Cardinal Health, Inc.
     11.5 CONMED Corporation
     11.6 Cook Group Incorporated
     11.7 HAKKO CO.,LTD Medical Device Division
     11.8 INRAD Inc.
     11.9 Medtronic, Plc
     11.10 Merit Medical Systems
     11.11 Olympus Corporation
     11.12 Ranfac Corporation
     11.13 Remington Medical Inc.
     11.14 Somatex Medical Technologies
     11.15 Stryker Corporation

*Business Overview, Products Offered, Recent Developments, MnM View Might Not be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 127)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (74 Tables)

Table 1 Aspiration and Biopsy Needles Market, By Product, 2017–2024 (USD Million)
Table 2 Biopsy Needles Market, By Type, 2017–2024 (USD Million)
Table 3 Biopsy Needles Market, By Region, 2017–2024 (USD Million)
Table 4 Biopsy Needles Market Split , By Site, 2017–2024, (USD Million)
Table 5 Biopsy Needles Market Split, By Procedure, 2017–2024, (USD Million)
Table 6 Biopsy Needles Market Split , By End User, 2017–2024, (USD Million)
Table 7 CNB Needles Market, By Region, 2017–2024 (USD Million)
Table 8 CNB Needles Market, By Site, 2017–2024, (USD Million)
Table 9 CNB Needles Market, By Procedure, 2017–2024, (USD Million)
Table 10 CNB Needles Market, By End User, 2017–2024, (USD Million)
Table 11 VAB Needles Market, By Region, 2017–2024 (USD Million)
Table 12 VAB Needles Market, By Site, 2017–2024, (USD Million)
Table 13 VAB Needles Market, By Procedure, 2017–2024, (USD Million)
Table 14 VAB Needles Market, By End User, 2017–2024, (USD Million)
Table 15 Aspiration Needles Market, By Region, 2017–2024 (USD Million)
Table 16 Aspiration Needles Market, By Site, 2017–2024, (USD Million)
Table 17 Aspiration Needles Market, By Procedure, 2017–2024, (USD Million)
Table 18 Aspiration Needles Split, By End User, 2017–2024, (USD Million)
Table 19 Fine Needle Aspiration Market, By Procedure, 2017–2024 (USD Million)
Table 20 Aspiration and Biopsy Needles Market for Image-Guided Procedures, By Type, 2017–2024 (USD Million)
Table 21 Aspiration and Biopsy Needles Market for Image-Guided Procedures, By Region, 2017–2024 (USD Million)
Table 22 Aspiration and Biopsy Needles Market for Ultrasound Procedures, By Region, 2017–2024 (USD Million)
Table 23 Aspiration and Biopsy Needles Market for Stereotactic Procedures, By Region, 2017–2024 (USD Million)
Table 24 Aspiration and Biopsy Needles Market for MRI Procedures, By Region, 2017–2024 (USD Million)
Table 25 Aspiration and Biopsy Needles Market for Other Image-Guided Procedures, By Region, 2017–2024 (USD Million)
Table 26 Aspiration and Biopsy Needles Market for Nonimage-Guided Procedures, By Region, 2017–2024 (USD Million)
Table 27 Aspiration and Biopsy Needles Market, By Site, 2017–2024 (USD Million)
Table 28 Aspiration and Biopsy Needles Market for Breast Procedures, By Region, 2017–2024 (USD Million)
Table 29 Aspiration and Biopsy Needles Market for Lung Procedures, By Region, 2017–2024 (USD Million)
Table 30 Aspiration and Biopsy Needles Market for Colorectal Procedures, By Region, 2017–2024 (USD Million)
Table 31 Aspiration and Biopsy Needles Market for Prostate Procedures, By Region, 2017–2024 (USD Million)
Table 32 Aspiration and Biopsy Needles Market for Kidney Procedures, By Region, 2017–2024 (USD Million)
Table 33 Aspiration and Biopsy Needles Market for Bone and Bone Marrow Procedures, By Region, 2017–2024 (USD Million)
Table 34 Aspiration and Biopsy Needles Market for Procedures at Other Sites, By Region, 2017–2024 (USD Million)
Table 35 Needle Aspiration Market, By Region, 2017–2024 (USD Million)
Table 36 North America: Needle Aspiration Market, By Country, 2017–2024 (USD Million)
Table 37 North America: FNA Biopsy Market, By Product, 2017–2024 (USD Million)
Table 38 North America: Biopsy Needles Market, By Product Type, 2017–2024 (USD Million)
Table 39 North America: FNA Biopsy Market, By Site, 2017–2024 (USD Million)
Table 40 North America: FNA Biopsy Market, By Procedure, 2017–2024 (USD Million)
Table 41 North America: Aspiration and Biopsy Needles Market for Image-Guided Procedure, By Type, 2017–2024 (USD Million)
Table 42 North America: Aspiration and Biopsy Needles Market, By End User, 2017–2024 (USD Million)
Table 43 Estimated New Cases of Cancer in 2019
Table 44 US: Needle Aspiration Market, By Product, 2017–2024 (USD Million)
Table 45 Canada: Needle Aspiration Market, By Product, 2017–2024 (USD Million)
Table 46 Europe: FNA Biopsy Market, By Country, 2017–2024 (USD Million)
Table 47 Europe: FNA Biopsy Market, By Product, 2017–2024 (USD Million)
Table 48 Europe: Biopsy Needles Market, By Product Type, 2017–2024 (USD Million)
Table 49 Europe: Aspiration and Biopsy Needles Market, By Site, 2017–2024 (USD Million)
Table 50 Europe: FNA Biopsy Market, By Procedure, 2017–2024 (USD Million)
Table 51 Europe: Aspiration and Biopsy Needles Market for Image-Guided Procedure, By Type, 2017–2024 (USD Million)
Table 52 Europe: Aspiration and Biopsy Needles Market, By End User, 2017–2024 (USD Million)
Table 53 Germany: Needle Aspiration Market, By Product, 2017–2024 (USD Million)
Table 54 UK: Fine Needle Aspiration Market, By Product, 2017–2024 (USD Million)
Table 55 France: Fine Needle Aspiration Market, By Product, 2017–2024 (USD Million)
Table 56 RoE: Needle Aspiration Market, By Product, 2017–2024 (USD Million)
Table 57 APAC: Fine Needle Aspiration Market, By Country, 2017–2024 (USD Million)
Table 58 APAC: FNA Biopsy Market, By Product, 2017–2024 (USD Million)
Table 59 APAC: Biopsy Needles Market, By Product Type, 2017–2024 (USD Million)
Table 60 APAC: FNA Biopsy Market, By Site, 2017–2024 (USD Million)
Table 61 APAC: FNA Biopsy Market, By Procedure, 2017–2024 (USD Million)
Table 62 APAC: Aspiration and Biopsy Needles Market for Image-Guided Procedure, By Type, 2017–2024 (USD Million)
Table 63 APAC: Aspiration and Biopsy Needles Market, By End User, 2017–2024 (USD Million)
Table 64 Japan: FNA Biopsy Market, By Product, 2017–2024 (USD Million)
Table 65 China: FNA Biopsy Market, By Product, 2017–2024 (USD Million)
Table 66 India: Aspiration and Biopsy Needles Market, By Product, 2017–2024 (USD Million)
Table 67 RoAPAC: Aspiration and Biopsy Needles Market, By Product, 2017–2024 (USD Million)
Table 68 RoW: Fine Needle Aspiration Market, By Product, 2017–2024 (USD Million)
Table 69 RoW: Biopsy Needles Market, By Product Type, 2017–2024 (USD Million)
Table 70 RoW: Aspiration and Biopsy Needles Market, By Site, 2017–2024 (USD Million)
Table 71 RoW: FNA Biopsy Market, By Procedure, 2017–2024 (USD Million)
Table 72 RoW: Aspiration and Biopsy Needles Market for Image-Guided Procedure, By Type, 2017–2024 (USD Million)
Table 73 RoW: Aspiration and Biopsy Needles Market, By End User, 2017–2024 (USD Million)
Table 74 Product Launches and Approvals
 
 
List of Figures (32 Figures)
 
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Research Methodology: Hypothesis Building
Figure 4 Product-Based Market Size Estimation: Aspiration and Biopsy Needles Market
Figure 5 End-User Based Estimation: Aspiration and Biopsy Needles Market
Figure 6 Aspiration and Biopsy Needles Market, By Product, 2019–2024 (USD Million)
Figure 7 Needle Aspiration Market, By Site, 2019–2024 (USD Million)
Figure 8 Aspiration and Biopsy Needles Market Share, By Procedure, 2019 vs 2024
Figure 9 Needle Aspiration Market, By End User, 2019–2024 (USD Million)
Figure 10 Needle Aspiration Market, By Region
Figure 11 Rising Prevalence of Cancer Globally is a Key Driver for the Market
Figure 12 Biopsy Needles Held the Largest Share of the Market in 2018
Figure 13 Hospitals Command the Largest Share of the Market
Figure 14 Image-Guidance Procedures Hold the Largest Share of the Market
Figure 15 Breast Procedures to Dominate the Market During the Forecast Period
Figure 16 APAC to Grow at the Highest CAGR During the Forecast Period
Figure 17 Aspiration and Biopsy Needles Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Incidence of Cancer, By Country/Region, 2012–2020 (Thousand)
Figure 19 North America: Aspiration and Biopsy Needles Market Snapshot
Figure 20 Europe: Aspiration and Biopsy Needles Market Snapshot
Figure 21 APAC: Needle Aspiration Market Snapshot
Figure 22 RoW: Needle Aspiration Market Snapshot
Figure 23 Aspiration and Biopsy Needles Market Ranking, By Key Player, 2018
Figure 24 Competitive Leadership Mapping (Overall Market)
Figure 25 BD: Company Snapshot
Figure 26 Boston Scientific Corporation: Company Snapshot-2018
Figure 27 Cardinal Health, Inc.: Company Snapshot
Figure 28 CONMED Corporation: Company Snapshot
Figure 29 Medtronic, PLC: Company Snapshot
Figure 30 Merit Medical Systems: Company Snapshot
Figure 31 Olympus Corporation: Company Snapshot
Figure 32 Stryker Corporation: Company Snapshot

This study involved four major activities in estimating the current size of the aspiration and biopsy needles market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation processes were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was conducted to obtain key information about the market classification and segmentation, geographical scenario, key developments undertaken by major market players, and the identification of key industry trends. The secondary sources used for this study include annual reports, press releases, and investor presentations of companies; white papers; certified publications; and articles from recognized websites, databases, and directories.

Primary Research

Extensive primary research was conducted after acquiring a preliminary understanding of the aspiration and biopsy needles market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as research/department heads at hospitals, medical device suppliers, surgical instrumentation supplies companies, product distributors, and channel partners) and supply-side respondents (such as C & D-level executives & product managers of key manufacturers, distributors, and channel partners) across North America, Europe, Asia Pacific, and the RoW. Approximately 30% and 70% of primary interviews were conducted with both the demand- and supply-side respondents, respectively. Primary data was collected through questionnaires, e-mails, online surveys, and telephonic interviews. A breakdown of primary respondents is provided below:

Aspiration & Biopsy Needles Market

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

  • A detailed market estimation approach was followed to estimate and validate the size of the aspiration and biopsy needles market and other dependent submarkets.
  • The key players in the aspiration and biopsy needles market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology includes the study of the annual and quarterly financial reports of top market players as well as interviews with industry experts to gather key insights on various market segments and subsegments.
  • All segmental shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • Major Macroindicators in play have been accounted for, viewed in detail, verified through primary research, and analyzed to understand their impact on market growth and various segments and subsegments.
  • The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Data Triangulation:

After deriving the overall aspiration and biopsy needles market value from the market size estimation process explained above, the total market value data was split into several segments and subsegments. Data triangulation and market breakdown procedures were undertaken to complete the overall market engineering process and arrive at the exact statistics for all segments, wherever applicable. The data was triangulated by studying various qualitative & quantitative variables as well as by analyzing regional trends for both the demand- and supply-side macroindicators.

Report Objectives:

  • To define, describe, and forecast the aspiration and biopsy needles market on the basis of product, site, procedure, end user, and region
  • To provide detailed information regarding the major factors influencing the aspiration and biopsy needles market (such as drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the aspiration and biopsy needles market.
  • To analyze key growth opportunities in the aspiration and biopsy needles market for key stakeholders and provide details of the competitive landscape for key market players
  • To forecast the market value of various segments and/or subsegments with respect to four major regional segments—North America, Europe, Asia Pacific, and the Rest of the World
  • To profile the key players in the aspiration and biopsy needles market and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments undertaken by major players in the aspiration and biopsy needles market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the aspiration and biopsy needles market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the aspiration and biopsy needles market.

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
Report Code
MD 7195
Published ON
Jun, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Aspiration & Biopsy Needles Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home